Intrinsic Value of S&P & Nasdaq Contact Us

Amarin Corporation plc AMRN NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IE • USD

SharesGrow Score
29/100
0/7 Pass
SharesGrow Intrinsic Value
$18.45
+26.8%
Analyst Price Target
$2.17
-85.1%

Amarin Corporation plc (AMRN) — Analyst outlook / Analyst consensus target is. Based on 18 analyst ratings, the consensus is bullish — 3 Buy, 13 Hold, 2 Sell.

The consensus price target is $2.17 (low: $1.50, high: $3.00), representing a downside of 85.1% from the current price $14.55.

Analysts estimate Earnings Per Share (EPS) of $-2.81 and revenue of $0.20B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.20 vs est $-2.81 (beat +92.9%). 2025: actual $-0.09 vs est $-0.66 (beat +86.4%). Analyst accuracy: 0%.

AMRN Stock — 12-Month Price Forecast

$2.17
▼ -85.09% Downside
Average Price Target
Based on 18 Wall Street analysts offering 12-month price targets for Amarin Corporation plc, the average price target is $2.17, with a high forecast of $3.00, and a low forecast of $1.50.
The average price target represents a -85.09% change from the last price of $14.55.
Highest Price Target
$3.00
Average Price Target
$2.17
Lowest Price Target
$1.50

AMRN Analyst Ratings

Hold
18
Ratings
3 Buy
13 Hold
2 Sell
Based on 18 analysts giving stock ratings to Amarin Corporation plc in the past 3 months
Rating breakdown
Buy
3 17%
Hold
13 72%
Sell
2 11%
17%
Buy
3 analysts
72%
Hold
13 analysts
11%
Sell
2 analysts

EPS Estimates — AMRN

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.20 vs Est –$2.81 ▲ 1,304.5% off
2025 Actual –$0.09 vs Est –$0.66 ▲ 635.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — AMRN

83%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.229B vs Est $0.202B ▲ 11.5% off
2025 Actual $0.183B vs Est $0.222B ▼ 21.7% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message